DARE Price Projection from Yahoo: With FDA approval of BV1- $12-15 If new partnership for sildenafil announced that should add a dollar or two as well. Ovaprene good phase 3 results and FDA approval in two to three years will spike this to $100/share and it will settle somewhere in the $60-$80 range. Now if BV1, Sildenafil Topical and Ovaprene all make it through regulatory this will be a multibillion $ company and share price $200.